Douglas Ingram
Overview
Douglas Ingram received an average of $13M in total compensation, including $607K in salary, at Sarepta Therapeutics from 2017 to 2021.
2021Sarepta TherapeuticsPresident and Chief Executive Officer
2020Sarepta TherapeuticsPresident and Chief Executive Officer
2019Sarepta TherapeuticsPresident and Chief Executive Officer
2018Sarepta TherapeuticsPresident and Chief Executive Officer
2017Sarepta TherapeuticsPresident and Chief Executive Officer
Source: SEC filings on April 25, 2022, April 20, 2021, April 21, 2020, April 26, 2019, and April 26, 2018.
Related executives
We found 30 more executives who work or worked at Sarepta Therapeutics.
Louise Rodino-Klapac
Sarepta Therapeutics
Chief Scientific Officer
Ian Estepan
Sarepta Therapeutics
Chief Financial Officer
Ryan Brown
Sarepta Therapeutics
General Counsel
William Ciambrone
Sarepta Therapeutics
Executive Vice President, Technical Operations
David Howton
Sarepta Therapeutics
General Counsel
Gilmore MMSc
Sarepta Therapeutics
Chief Scientific Officer
Sandesh Mahatme
Sarepta Therapeutics
Chief Financial Officer
Joseph Bratica
Sarepta Therapeutics
Vice President, Corporate Controller
News
Sarepta Therapeutics CSO Louise Rodino-Klapac's 2021 pay rises 17% to $8.5M
April 25, 2022
Sarepta Therapeutics CSO Louise Rodino-Klapac receives $7.3M in 2020
April 20, 2021
Sarepta Therapeutics CSO Gilmore MMSc's 2019 pay slips 20% to $5.2M
April 21, 2020
Sarepta Therapeutics CSO Gilmore MMSc receives $6.4M in 2018
April 26, 2019